EMAN - NFLX TELL CLBS and FUTU among notable pre-market gainers

Caladrius Biosciences (CLBS) +120%.Aptorum Group (APM) +61% as Canada approves early-stage infection drug trial.Steel Connect (STCN) +54%.Dare Bioscience (DARE) +39%.ENDRA Life Sciences (NDRA) +36%.Lineage Cell Therapeutics (LCTX) +34%.Inuvo (INUV) +33%.eMagin Corporation (EMAN) +28%.Avinger (AVGR) +19%.AIkido Pharma (AIKI) +20%.AgEagle Aerial Systems (UAVS) +18%.Koss Corporation (KOSS) +17%.Isoray (ISR) +16%.PCTEL (PCTI) +16%.Tellurian (TELL) +15%.Hall of Fame Resort & Entertainment (HOFV) +11% on announcing partnership with Tupelo Honey.Netflix (NFLX) +14% on Q4 results.SPI Energy (SPI) +13% as it's subsidiary appointed Edmund Shen (early Tesla employee) as its new Vice President.Titan Medical (TMDI) +13%.Senseonics Holdings (SENS) +13%.Sesen Bio (SESN) +13%.Futu Holdings Limited (FUTU) +12%.Edesa Biotech (EDSA) +12%.iClick Interactive Asia Group (ICLK) +11%.

For further details see:

NFLX, TELL, CLBS, and FUTU among notable pre-market gainers